Genpharmasec

Genpharmasec

1.94
+0.03
(1.57%)
Market Cap
107.46 Cr
EPS
0.01
PE Ratio
47.75
Dividend Yield
0.00 %
52 Week High
4.32
52 Week Low
1.84
PB Ratio
1.62
Debt to Equity
0.09
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Genpharmasec Limited approved its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. On a standalone basis, the company reported revenue from operations of Rs 1,211.32 lakhs compared to Rs 530.29 lakhs in the same quarter last year, representing significant growth. Profit for the period increased to Rs 155.92 lakhs from Rs 58.87 lakhs year-over-year. On a consolidated basis, revenue from operations reached Rs 1,204.32 lakhs versus Rs 519.50 lakhs in the previous year quarter, with consolidated profit of Rs 121.52 lakhs compared to Rs 28.68 lakhs. The company operates primarily in pharmaceuticals and laboratory testing segments through its subsidiaries Clinigenome India Private Limited and Genpharmasec Middle East DMCC. Basic earnings per share improved to Rs 0.03 on standalone basis and Rs 0.02 on consolidated basis. The results were reviewed by the audit committee and approved by the board on August 7, 2025.
positive
Genpharmasec Limited has completed the acquisition of a 70% stake in Derren Healthcare Private Limited for INR 34.15 crores, making it a subsidiary. The acquisition was completed on July 25, 2025, following agreements signed in September 2023. Derren Healthcare operates in pharmaceutical formulations with a turnover of INR 858.82 lacs for the financial year ended March 31, 2025. The company is a research-oriented firm focused on developing high-quality pharmaceutical products in generics and innovative finished formulations, also providing Contract Research Organization and CDMO services. The acquisition allows Genpharmasec to expand its activities and enter formulation manufacturing. Derren Healthcare was incorporated on October 8, 2018, and has shown significant growth with turnovers of INR 70.24 lacs in 2022-23, INR 627.69 lacs in 2023-24, and INR 858.82 lacs in 2024-25.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
177.00
#1 28,293.44
383.18
548.76
-23.08
70
72.10
27.09
288.14
22,526.05
20.16
#1 99,561.70
11.11
#1 1,821
7.37
72.84
66.34
9,951.00
140.57
262.80
-94.36
87
35.47
56.78
521.75
3,673.12
17.30
387.50
9.35
407
7.63
64.50
368.60
3,603.94
80.79
299.41
#1 8,85,900.00
20
#1 1,157.89
65.53
179.46
3,204.34
61.33
262.20
-
23
307.14
87.31
155.38
1,977.73
40.97
308.52
108.37
40
208.70
64.81
517.50
1,846.05
38.15
83.22
6,408.33
41
74.07
39.34
49.80
1,672.06
487.22
81.30
-9.60
3
0.00
52.08
37,125.00
1,141.15
#1 10.22
67.60
-16.34
115
-19.54
42.54
Forecast
Actual
Growth Rate
Revenue Growth
21.48 %
Net Income Growth
-118.18 %
Cash Flow Change
3.59 %
ROE
-103.54 %
ROCE
-49.47 %
EBITDA Margin (Avg.)
62.05 %

Quarterly Financial Results

Quarterly Financials
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
6
6
8
7
11
6
7
9
15
13
Expenses
6
6
8
6
10
5
6
8
15
11
EBITDA
0
0
0
0
0
1
1
2
-0
2
Operating Profit %
3 %
0 %
-1 %
0 %
-0 %
4 %
2 %
9 %
-7 %
8 %
Depreciation
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
0
0
0
0
1
1
1
-0
1
Tax
-1
0
0
0
0
0
-0
1
-0
0
Net Profit
1
0
0
0
-0
0
1
1
-0
1
EPS in ₹
0.04
0.00
0.00
0.00
0.01
0.01
0.01
0.01
-0.01
0.02

Balance Sheet

Balance Sheet
2023
2024
2025
Total Assets
20
71
80
Fixed Assets
0
1
8
Current Assets
19
41
28
Capital Work in Progress
0
0
0
Investments
1
19
8
Other Assets
19
51
0
Total Liabilities
20
71
80
Current Liabilities
2
3
10
Non Current Liabilities
3
4
5
Total Equity
15
65
65
Reserve & Surplus
-12
9
10
Share Capital
28
55
55

Cash Flow

Cash Flow
2023
2024
Net Cash Flow
0
17
Investing Activities
0
-28
Operating Activities
-3
-3
Financing Activities
3
48

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Feb 2024
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
59.96 %
59.96 %
59.96 %
59.96 %
59.96 %
59.96 %
59.96 %
59.96 %
59.96 %
59.96 %
59.96 %
59.96 %
29.98 %
29.98 %
29.98 %
29.98 %
29.98 %
29.98 %
29.98 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
24.56 %
24.43 %
25.21 %
26.18 %
30.02 %
30.36 %
30.58 %
30.57 %
30.13 %
31.81 %
32.82 %
33.81 %
52.78 %
56.17 %
61.26 %
59.55 %
59.62 %
59.94 %
60.03 %
Others
15.49 %
15.61 %
14.83 %
13.86 %
10.03 %
9.68 %
9.46 %
9.47 %
9.91 %
8.23 %
7.21 %
6.23 %
17.24 %
13.84 %
8.76 %
10.47 %
10.40 %
10.08 %
9.99 %
No of Share Holders
0
6,265
9,559
17,121
24,134
54,007
53,404
53,266
49,760
48,868
54,458
89,438
1,05,693
1,08,137
1,08,220
1,05,838
1,09,206
1,09,080
1,07,602

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 1.93 1.91
06 Sept 2021 CHANGE OF NAME Change Of Name
NA
06 Sept 2021 4.97 4.97
09 Jan 2024 RIGHTS Rights
1:1
09 Jan 2024 2.87 5.23
23 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Jul 2024 1.99 2.20
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 3.14 2.95
10 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2025 2.53 2.24
21 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 May 2025 2.05 2.24
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 1.99 1.99

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 06, 2025
Reg. 34 (1) Annual Report.Sep 05, 2025
Notice Of 33Rd Annual General Meeting Of The Company To Be Held On September 29 2025. Sep 05, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sSep 02, 2025
Intimation Of Book Closure For Annual General MeetingSep 02, 2025
Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Tuesday 02Nd September 2025.Sep 02, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday 02Nd September 2025.Aug 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th June 2025.Aug 07, 2025
Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter Ended 30Th June 2025. Aug 07, 2025
Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Thursday 07Th August 2025.Aug 07, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 07Th August 2025.Aug 01, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJul 25, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Closure of Trading WindowJun 26, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2025
Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 31St March 2025.May 21, 2025
Audited Standalone & Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended 31St March 2025.May 21, 2025
Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Wednesday May 21 2025.May 21, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday 21St May 2025.May 13, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Closure of Trading WindowMar 25, 2025
Board Meeting Outcome for Outcome Of The Separate Meeting Of Independent Directors Of The Company.Mar 24, 2025
Board Meeting Intimation for Separate Meeting Of Independent Directors Of The Company To Be Held On Monday March 24 2025.Mar 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2025
Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 31St December 2024.Feb 10, 2025
Integrated Filing (Financial)Feb 10, 2025
Result - Financial Results For The Quarter And Nine Months Ended December 31 2024.Feb 10, 2025
Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Monday February 10 2025.Feb 10, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday 10Th February 2025.Feb 03, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 10, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2024
Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th September, 2024.Nov 12, 2024
Unaudited Standalone & Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2024.Nov 12, 2024
Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Tuesday, November 12, 2024.Nov 12, 2024
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday, 12Th November, 2024.Nov 05, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 08, 2024
Closure of Trading WindowSep 26, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 15, 2024
Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th June, 2024.Aug 13, 2024
Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter Ended 30Th June, 2024.Aug 13, 2024
Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Tuesday, August 13, 2024.Aug 13, 2024
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday, 13Th August, 2024.Aug 05, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportJul 23, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 23, 2024
Reg. 34 (1) Annual Report.Jul 11, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 08, 2024

Technical Indicators

RSI(14)
Neutral
47.40
ATR(14)
Volatile
0.08
STOCH(9,6)
Neutral
45.37
STOCH RSI(14)
Neutral
47.88
MACD(12,26)
Bullish
0.00
ADX(14)
Weak Trend
15.40
UO(9)
Bearish
39.46
ROC(12)
Downtrend And Accelerating
0.00
WillR(14)
Neutral
-70.00